Volume 51, Issue 1, Pages 6-8 (January 2007)
The discovery of prostate-specific antigen (PSA) almost two decades ago and its introduction into clinical practice has revolutionised the management of prostate cancer [1].
Your session will expire in 8 hours requiring you to log in each day to view content.
FEBRUARY 16, 2012